About Our Company
At Rejuvenate Bio, we are developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies. We launched out of George Church's lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Leadership Team
George Church, Ph.D.
Co-Founder and SAB
Daniel Oliver, MBA
CEO, Co-Founder
Noah Davidsohn, Ph.D.
CSO, Co-Founder
Deborah Ascheim, M.D.
Chief Medical Officer